Global Pet Medications Market Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

$5,000$10,000

Pet Medications Market Size & Share to Show Highest Growth During Forecast Period 2020-2030

Clear
SKU: FPG0660 Category: Tag:

Description

Pet Medications Market

Market Overview
‘’Pet Medication,” are the medications that help companion animals and farm animals to prevent and treat diseases, as well as improve and lengthen their lives. Parasiticides, vaccinations, anti-infectives, medicinal feed additives, and other items are among them. The worldwide pet medicine market is expected to rise, owing to the rising trend of pet humanization and the subsequent commercialization of a wide range of pet care products, as well as a growing focus on safe food and a corresponding emphasis on breeding healthy livestock. The expanding tendency of nuclear families and rising disposable income of pet owners in the medium income group are the primary critical causes for the growth of the pet care industry in the next years.

Pet Medications Market: Key Players
Zoetis

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

Merck
Merial
Elanco
Bayer
Boehringer
Novartis
Virbac
Ceva
Vetoquinol
Nexvet
Aratana Therapeutics
Kindred Biosciences

Growth Factor
Increasing Pet adoption
Pet adoption is on the rise, and there is a significant demand for pet items, which is propelling the worldwide pet medicines market forward. Weight management, obesity-related illnesses such as diabetes and joint pain, immunological response, heart health, and cognitive support, as well as anti-inflammation and pain management medications, are all needed for an increasing number of aged dogs and cats.

Growing pet parent awareness of the health and well-being of their pets
The COVID-19 pandemic’s emphasis on health protection, as well as the resulting shift to stay-at-home lifestyles, raised pet parent awareness of their pets’ health and well-being. Despite early failures and hurdles, the veterinary industry—which accounts for 72 percent of global prescription and over-the-counter pet pharmaceutical sales, according to Packaged Facts—managed to close the year with stronger-than-average growth.

Segmentation
By Product Type
Antibiotics
Antimicrobials
Antiparasitics
Chemotherapeutics
By Application
Cat
Dog
Horse
Fish
Other
Pet Medications Market Dynamics
Pet Medications Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints

Recent News Related to Market
In 2019, Dogs, cats, birds, and fish and reptiles are the most popular OTC pet medications, accounting for over 87 percent of the overall OTC pet drug market share.
In July 2018, Zoetis bought Abaxis, a pioneer in veterinary point-of-care diagnostic tools. This allowed Zoetis to broaden its product offering.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
COVID-19 pre and post business impact analysis
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
What is the Pet Medications Market growth?
Which segment accounted for the largest Pet Medications Market share?
Who are the key players in the Pet Medications Market?
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Additional information

Publisher

Geography Covered

Date Published

,

Pages

Format

Table of Contents

Contents
1. Executive Summary
2. Global Pet Medications Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Global Pet Medications Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Global Pet Medications Market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. Global Pet Medications Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Europe: (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Asia-Pacific: (China, India, Japan, South Korea, Australia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Latin America: (Brazil, Mexico, Argentina), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. MEA: (South Africa and Saudi Arabia), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Product: Market Share (2020-2030F)
12.2.1. Antibiotics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Antimicrobials, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Antiparasitics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.4. Chemotherapeutics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Application: Market Share (2020-2030F)
12.3.1. Cat, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Dog, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Horse, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.4. Fish, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.5. Other, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
13. Company Profile
13.1. Zoetis
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Merck
13.3. Merial
13.4. Elanco
13.5. Bayer
13.6. Boehringer
13.7. Novartis
13.8. Virbac
13.9. Ceva
13.10. Vetoquinol
13.11. Nexvet
13.12. Aratana Therapeutics
13.13. Kindred Biosciences
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.